Biochemical and cellular pharmacology of cytosine arabinoside
Kufe, D.W.; Spriggs, D.R.
Seminars in Oncology 12(2 Suppl 3: 34-48
1985
ISSN/ISBN: 0093-7754 PMID: 3925560 Document Number: 265203
Document emailed within 1 workday
Related Documents
Takemoto, Y.; Sampi, K.; Kuraishi, Y.; Okabe, K.; Tamura, K.; Mizoguchi, H.; Saito, H.; Masaoka, T.; Ogawa, M. 1999: A prospective randomized trial of KRN8602 and cytosine arabinoside vs. daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia. the KRN8602 Leukemia Study Group International Journal of Hematology 70(1): 20-25Peterlejtner, E. 1978: Ophthalmic zoster treated with cytosine arabinoside Klinika Oczna 48(2): 71-72
Madon, E.; Baroncelli, P.G.; Sacerdote, A.; Roberi, P.L. 1971: Treatment of acute leukemias in the infancy with cytosine arabinoside Minerva Pediatrica 23(26): 1125-1129
Derulska, D.; Rokicka-Milewska, R. 1975: Cytosine arabinoside in the treatment of acute leukemia in children Pediatria Polska 50(6): 723-728
Gallo, J.H.; Rozenberg, M.C. 1986: Response of refractory anemia to low-dose cytosine arabinoside Australian and New Zealand Journal of Medicine 16(2): 231-233
Tatsumi, N.; Masaoka, T.; Ueda, Y.; Senda, N. 1970: Treatment of leukemia with cytosine arabinoside--on the intensification of remission Gan no Rinsho. Japan Journal of Cancer Clinics 16(7): 706-712
Hanka, L.J.; Kuentzel, S.L.; Neil, G.L. 1970: Improved microbiological assay for cytosine arabinoside (NSC-63878) Cancer ChemoTherapy Reports 54(6): 393-397
Pytel-Dabrowska, T.; Balcar-Boroń, A.; Nowaczyk-Michalak, A. 1980: Cytosine arabinoside in the treatment of herpes simplex and chickenpox Wiadomosci Lekarskie 33(12): 957-959
Rose, W.C.; Trader, M.W.; Laster, W.R.; Schabel, F.M. 1978: Chronochemotherapy of L1210 leukemic mice with cytosine arabinoside or cyclophosphamide Cancer Treatment Reports 62(9): 1337-1349
Hirschmann, W.D.; Kovacs, E.L.; Gerecke, D.; Kaulen, H.D.; Voigtmann, R.; Gross, R. 1975: Method of administration and inactivation of cytosine arabinoside in acute leukemia Verhandlungen der Deutschen Gesellschaft für Innere Medizin 81: 1114-1116
Yang, G.S.; Minden, M.D.; McCulloch, E.A. 1993: Influence of schedule on regulated sensitivity of AML blasts to cytosine arabinoside Leukemia 7(7): 1012-1019
Bassetti, D.; Giacchino, R.; Dimic, E. 1974: Varicella pneumonia in an agammaglobulinemic patient cured by cytosine-arabinoside Panminerva Medica 16(5-6): 177-180
Goudsmit, R. 1972: Cytosine arabinoside in the treatment of severe herpes zoster and varicella Nederlands Tijdschrift Voor Geneeskunde 116(5): 200
Surkova, N.I.; Malashenko, A.M. 1975: Cytogenetic effect of mitomycin C and cytosine arabinoside on mice of different genotypes Genetika 11(9): 38-45
Morrison, P.F.; Lincoln, T.L.; Aroesty, J. 1975: Disposition of cytosine arabinoside (NSC-63878) and its metabolites: a pharmacokinetic simulation Cancer ChemoTherapy Reports 59(4): 861-876
Wdzieczak-Bakala, J.; Guigon, M.; Lenfant, M.; Frindel, E. 1983: Further purification of a CFU-S inhibitor: in vivo effects after cytosine arabinoside treatment Biomedicine and PharmacoTherapy 37(9-10): 467-471
Kreis, W.; Woodcock, T.M.; Gordon, C.S.; Krakoff, I.H. 1977: Tetrahydrouridine: Physiologic disposition and effect upon deamination of cytosine arabinoside in man Cancer Treatment Reports 61(7): 1347-1353
Klener, P.; Háber, J. 1985: Treatment of refractory leukemia with high-dose cytosine arabinoside Neoplasma 32(1): 113-117
Lin, S.F.; Liu, H.W.; Chen, T.P. 1990: Chemotherapy for acute non-lymphocytic leukemia with low-dose cytosine arabinoside (Ara-C) Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 53(1): 45-50
Herzig, R.H.; Herzig, G.P.; Wolff, S.N.; Hines, J.D.; Fay, J.W.; Phillips, G.L. 1987: Central nervous system effects of high-dose cytosine arabinoside Seminars in Oncology 14(2 Suppl 1: 21-24